Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures

NCT03393780 · clinicaltrials.gov ↗

COMPLETED

Status

1018

Enrollment

INDUSTRY

Sponsor class

Conditions

Controlled Ovarian Stimulation

Interventions

DRUG: Follitropin Delta

Sponsor

Ferring Pharmaceuticals